2 results
Approved WMOWill not start
The primary objective of this study is to further evaluate the safety and tolerability of pegaptanib sodium in subjects with DME.
Approved WMOCompleted
*To demonstrate comparability of the ORR in patients with previously untreated, advanced stage FL who receive GP2013-CVP combination treatment to patients who receive MabThera®-CVP treatment. ORR will be determined during the combination treatment…